Seeing Is Believing
BCAB is currently covered by 5 analysts with an average price target of $10.44. This is a potential upside of $10.01 (2327.91%) from yesterday's end of day stock price of $0.43.
Bioatla 's activity chart (see below) currently has 16 price targets and 28 ratings on display. The stock rating distribution of BCAB is 93.75% BUY and 6.25% HOLD.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 12.14 days.
Highest price target for BCAB is $5, Lowest price target is $5, average price target is $5.
Most recent stock forecast was given by RENI BENJAMIN from JMP on 16-Sep-2024.
Currently out of the existing stock ratings of BCAB, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$3.56 (247.22%)
$5
7 months 24 days ago
(16-Sep-2024)
0/7 (0%)
$3.31 (195.86%)
Buy
$87
2 years 1 months 12 days ago
(28-Mar-2023)
1/2 (50%)
$29.63 (51.65%)
14
Hold
$8
$6.56 (455.56%)
$8
2 years 1 months 16 days ago
(24-Mar-2023)
4/6 (66.67%)
$5.64 (238.98%)
71
Buy
$20
$18.56 (1288.89%)
$25
2 years 9 months ago
(10-Aug-2022)
0/2 (0%)
$13.39 (202.57%)
Buy
$64
3 years 5 months 21 days ago
(19-Nov-2021)
0/1 (0%)
$18.11 (39.46%)
What is BCAB (Bioatla ) average time for price targets to be met?
Which analyst has the current highest performing score on BCAB (Bioatla ) with a proven track record?
Which analyst has the current lower performing score on BCAB (Bioatla ) with a proven track record?
Which analyst has the most public recommendations on BCAB (Bioatla )?
Which analyst is the currently most bullish on BCAB (Bioatla )?
Which analyst is the currently most reserved on BCAB (Bioatla )?